Kagamigahara, Japan

Takeshi Nakagawa


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takeshi Nakagawa: Innovator in Capsule Sealing Technology

Introduction

Takeshi Nakagawa is an accomplished inventor based in Kagamigahara, Japan. With a focus on enhancing pharmaceutical delivery systems, he holds two patents that showcase his innovative approach in the field of gelatin hard capsules. Nakagawa's contributions have not only advanced technology but also improved the efficiency of drug delivery.

Latest Patents

Takeshi Nakagawa's latest patents include a groundbreaking process for sealing the body and cap of gelatin hard capsules. This invention details a method that involves successively dipping gelatin hard capsules containing drugs into a mixed solvent of water and ethanol, with a volume ratio of water to ethanol between 50-55%. After dipping, each capsule is taken out of the solvent and dried individually, ensuring a sealed structure that maintains the integrity and efficacy of the pharmaceutical content.

Career Highlights

Currently, Nakagawa is employed at Eisai Company, Limited, where he contributes his expertise to develop innovative solutions in the pharmaceutical industry. His career is marked by a commitment to advancing drug delivery techniques, which has positioned him as a key player in the field of pharmaceutical technology.

Collaborations

Throughout his career, Nakagawa has collaborated with notable colleagues such as Shigeru Sakashita and Takayuki Ohwaki. These partnerships have fostered an environment of creativity and shared knowledge, further driving innovations in capsule sealing technology.

Conclusion

Takeshi Nakagawa's work in the realm of gelatin hard capsules illustrates the importance of innovation in the pharmaceutical industry. His patents not only reflect his technical acumen but also his dedication to improving drug delivery systems. As he continues his research at Eisai Company, Limited, Nakagawa remains a significant figure in the field of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…